|
VTV Therapeutics Inc. (VTVT) DCF -Bewertung
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
vTv Therapeutics Inc. (VTVT) Bundle
Unabhängig davon, ob Sie ein Investor oder ein Analyst sind, ist dieser (VTVT) DCF-Taschenrechner Ihr Anlaufwerk für eine genaue Bewertung. Vorausgeladen mit realen Daten von VTV Therapeutics Inc., können Sie Prognosen anpassen und die Auswirkungen sofort beobachten.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.8 | 6.4 | 4.0 | 2.0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 132.05 | -37.56 | -49.61 | -100 | -21.79 | -21.79 | -21.79 | -21.79 | -21.79 |
| EBITDA | -20.0 | -12.0 | -17.5 | -24.8 | -25.4 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | -722.58 | -187.34 | -437.33 | -1227.25 | 100 | -60 | -60 | -60 | -60 | -60 |
| Depreciation | .0 | .1 | .1 | .1 | .1 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 1.41 | 1.47 | 2.22 | 4.56 | 100 | 21.93 | 21.93 | 21.93 | 21.93 | 21.93 |
| EBIT | -20.0 | -12.1 | -17.6 | -24.9 | -25.5 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | -723.99 | -188.81 | -439.55 | -1231.81 | 100 | -60 | -60 | -60 | -60 | -60 |
| Total Cash | 1.8 | 5.7 | 13.4 | 12.1 | 9.4 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .2 | .1 | 12.4 | .1 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 0.1809 | 2.46 | 1.42 | 615.26 | 100 | 40.81 | 40.81 | 40.81 | 40.81 | 40.81 |
| Inventories | .3 | .4 | .1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 9.04 | 5.78 | 2.5 | 0.74331 | 100 | 23.61 | 23.61 | 23.61 | 23.61 | 23.61 |
| Accounts Payable | 2.2 | 1.9 | 1.9 | 2.5 | 4.1 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 80.75 | 30.01 | 46.84 | 121.95 | 100 | 71.52 | 71.52 | 71.52 | 71.52 | 71.52 |
| Capital Expenditure | -.1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | -2.53 | 0 | 0 | -1.04 | 100 | -0.71464 | -0.71464 | -0.71464 | -0.71464 | -0.71464 |
| Tax Rate, % | 22.01 | 22.01 | 22.01 | 22.01 | 22.01 | 22.01 | 22.01 | 22.01 | 22.01 | 22.01 |
| EBITAT | -20.1 | -8.3 | -17.7 | -25.1 | -19.9 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -18.2 | -8.8 | -17.3 | -36.7 | -5.9 | -4.0 | .0 | .0 | .0 | .0 |
| WACC, % | 7.4 | 7.38 | 7.4 | 7.4 | 7.39 | 7.39 | 7.39 | 7.39 | 7.39 | 7.39 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -3.7 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -4 | |||||||||
| Net Debt | -9 | |||||||||
| Equity Value | 5 | |||||||||
| Diluted Shares Outstanding, MM | 2 | |||||||||
| Equity Value Per Share | 2.50 |
What You Will Get
- Real VTVT Financial Data: Pre-filled with vTv Therapeutics Inc.'s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See vTv Therapeutics Inc.'s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive DCF Calculator: Features both unlevered and levered DCF valuation models tailored for vTv Therapeutics Inc. (VTVT).
- WACC Calculator: A pre-configured Weighted Average Cost of Capital sheet with adjustable parameters.
- Customizable Forecast Assumptions: Easily alter growth rates, capital expenditures, and discount rates.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to vTv Therapeutics Inc. (VTVT).
- Interactive Dashboard and Charts: Visual representations that encapsulate essential valuation metrics for straightforward analysis.
How It Works
- Download: Obtain the pre-formatted Excel file containing vTv Therapeutics Inc.'s (VTVT) financial data.
- Customize: Modify projections, including revenue growth, EBITDA %, and WACC as needed.
- Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Generate various forecasts and evaluate results immediately.
- Make Decisions: Leverage the valuation findings to inform your investment approach.
Why Choose This Calculator for vTv Therapeutics Inc. (VTVT)?
- User-Friendly Interface: Tailored for both novice and seasoned users.
- Customizable Inputs: Modify assumptions effortlessly to suit your analysis needs.
- Real-Time Valuation: Observe immediate updates to vTv Therapeutics' valuation as you adjust parameters.
- Preloaded Data: Comes equipped with vTv Therapeutics' actual financial metrics for swift evaluations.
- Relied Upon by Experts: Favored by investors and analysts for making well-informed choices.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive and accurate valuation models for portfolio management related to vTv Therapeutics Inc. (VTVT).
- Pharmaceutical Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
- Consultants and Advisors: Deliver precise valuation insights for clients interested in vTv Therapeutics Inc. (VTVT).
- Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
- Biotech Enthusiasts: Gain insights into how biotech companies like vTv Therapeutics Inc. (VTVT) are assessed in the financial markets.
What the Template Contains
- Historical Data: Includes vTv Therapeutics Inc.'s past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate vTv Therapeutics Inc.'s intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of vTv Therapeutics Inc.'s financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.